Eisai Gives Full Aduhelm Responsibility To Biogen Under Amended Agreement

Japanese Pharma Trades 50-50 Deal For Single-Digit Royalty

Close-up Of A Businessperson Passing Baton
Eisai passed full Aduhelm decision-making authority to Biogen • Source: Alamy

More from Deals

More from Business